Document is current

Any future updates will be listed below

Optimizing Cardiovascular Safety: Cardiotoxicity Prevention in Tyrosine Kinase Inhibitor, Monoclonal Antibody, Proteasome Inhibitor, and 5-Fluorouracil Anticancer Therapies

Crossref DOI link: https://doi.org/10.1007/978-3-031-97517-2_7

Published Online: 2025-10-01

Published Print: 2025

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark